Abstract

Through its interactions with proteins and proteoglycans, thrombospondin-1 (TSP-1) functions at the interface of the cell membrane and the extracellular matrix to regulate matrix structure and cellular phenotype. We have previously determined the structure of the high affinity heparin-binding domain of TSP-1, designated TSPN-1, in association with the synthetic heparin, Arixtra. To establish that the binding of TSPN-1 to Arixtra is representative of the association with naturally occurring heparins, we have determined the structures of TSPN-1 in complex with heparin oligosaccharides containing eight (dp8) and ten (dp10) subunits, by x-ray crystallography. We have found that dp8 and dp10 bind to TSPN-1 in a manner similar to Arixtra and that dp8 and dp10 induce the formation of trans and cis TSPN-1 dimers, respectively. In silico docking calculations partnered with our crystal structures support the importance of arginine residues in positions 29, 42, and 77 in binding sulfate groups of the dp8 and dp10 forms of heparin. The ability of several TSPN-1 domains to bind to glycosaminoglycans simultaneously probably increases the affinity of binding through multivalent interactions. The formation of cis and trans dimers of the TSPN-1 domain with relatively short segments of heparin further enhances the ability of TSP-1 to participate in high affinity binding to glycosaminoglycans. Dimer formation may also involve TSPN-1 domains from two separate TSP-1 molecules. This association would enable glycosaminoglycans to cluster TSP-1.

Highlights

  • Thrombospondin-1 (TSP-1)4 is a secreted glycoprotein that functions during the tissue remodeling that is associated with development, wound healing, synaptogenesis, angiogenesis, and cancer

  • TSPN11⁄7dp10 Co-crystal Structure—The fractionated heparin dp10 was co-crystallized with TSPN-1 under the condition of 30% polyethylene glycol 1500, 0.08 M sodium acetate at pH 4.6

  • We have previously reported the structure of TSPN-1 in association with the synthetic heparin, Arixtra (15)

Read more

Summary

EXPERIMENTAL PROCEDURES

Preparation of Recombinant TSPN-1—A recombinant version of the TSPN-1 (amino acids 1–240 of human TSP-1) was prepared as described previously (15). TSPN-1 structures from their co-crystallized complexes with heparin ligands dp and dp were used as the starting coordinates for our docking calculations. The Lamarckian genetic algorithm parameters used for the present docking study of both dp and dp heparin oligomers docked to the TSPN-1 dimer structure were as follows: the initial population of 50 randomly placed individuals, a maximum number of 25 ϫ 105 energy evaluations or a maximum number of 27,000 generations, a mutation rate of 0.02, a crossover ratio of 0.80; an elitism value of 1, probability of performing local search on an individual was set to a frequency of 0.06, a maximum number of consecutive success or failures before doubling or halving the local search step size was 4, and a maximum of 800 iterations per local search. For each of the TSPN-1 complexes we calculated 20 independent docking runs, and only the lowest energy confirmation is presented

RESULTS
6–7 O-linkage COOϪ of 7th sugar
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call